Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

hepatitis E vaccine

Known as: Hep E 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
The first prophylactic vaccine against hepatitis E virus (HEV), Hecolin®, was licensed in China. Recombinant p239 virus-like… Expand
Is this relevant?
2016
2016
Vaccine-based immunotherapy plays an integral role in the development of present and future clinical therapies. Despite the… Expand
Is this relevant?
2015
2015
BACKGROUND The first commercialized hepatitis E vaccine, HEV 239, has been shown to be safe and highly immunogenic, the… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?